tradingkey.logo

BUZZ-Street View: CVS Health to thrive with Aetna stabilization

ReutersFeb 13, 2025 9:58 AM

Healthcare conglomerate CVS Health CVS.N beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met expectations

Results and forecast hinted at an improvement in performance in its first full quarter under new CEO David Joyner

Median PT of 29 brokerages covering CVS is $65 - according to data compiled by LSEG

DOSE OF STABILITY

Leerink Partners ("outperform", PT: $75) sees CVS stabilizing, particularly with health insurance unit Aetna

Jefferies ("buy", PT: $74) sees CVS' stabilization of Aetna leading to early success in 2025 with low downside risk, and projected further EPS and increase in stock price if elevated use of medical services by its members subsides

Morgan Stanley ("overweight", PT: $68) sees potential earnings upside for CVS in 2025 from improved cost trends and Medicare Advantage (MA) margins

Evercore ISI ("outperform", PT: $80) sees CVS balanced, with realistic expectations for Medicaid rate and MA operating margin improvements, and also highlighted continued underlying improvements in its insurance unit

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI